| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EOG | Common Stock | +Options Exercise | $6,737,315 | +69,969 | +9.82% | $96.29 | 782,666 | Aug 18, 2022 | Direct | |
| transaction | EOG | Common Stock | -Disposed to Issuer | -$6,737,324 | -57,732 | -7.38% | $116.70 | 724,934 | Aug 18, 2022 | Direct | |
| transaction | EOG | Common Stock | -Tax liability | -$562,027 | -4,816 | -0.66% | $116.70 | 720,118 | Aug 18, 2022 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EOG | Stock Appreciation Rights | -Options Exercise | $0 | -69,969 | -100% | $0.00 | 0 | Aug 18, 2022 | Common Stock | 69,969 | $96.29 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The SARs granted became exercisable in increments of 33%, 33% and 34% on each of the first three anniversaries, respectively, of the September 25, 2017 date of grant. The SARs granted became fully exercisable on September 25, 2020 and would have expired on March 30, 2023. This exercise did not involve any open-market sale of the Issuer's Common Stock. |